We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IFF icon
376
International Flavors & Fragrances
IFF
$19.4B
$1.29M 0.03%
10,213
+4,559
+81% +$564K
ZTS icon
377
Zoetis
ZTS
$31.6B
$1.28M 0.03%
27,049
-28,036
-51% -$1.32M
FIS icon
378
Fidelity National Information Services
FIS
$21.5B
$1.28M 0.03%
17,358
+10,167
+141% +$715K
TROW icon
379
T. Rowe Price
TROW
$25B
$1.27M 0.03%
17,470
-2,901
-14% -$216K
MTB icon
380
M&T Bank
MTB
$36.2B
$1.27M 0.03%
10,739
+5,851
+120% +$679K
REG icon
381
Regency Centers
REG
$15B
$1.26M 0.03%
15,099
-435
-3% -$33.5K
TSM icon
382
TSMC
TSM
$2.09T
$1.23M 0.03%
47,000
– –
MHK icon
383
Mohawk Industries
MHK
$6.9B
$1.22M 0.03%
6,440
+3,600
+127% +$701K
MGM icon
384
MGM Resorts International
MGM
$11.7B
$1.22M 0.03%
53,698
+14,802
+38% +$336K
AZN icon
385
AstraZeneca
AZN
$263B
$1.21M 0.03%
+20,000
New +$1.16M
PXD
386
DELISTED
Pioneer Natural Resource Co.
PXD
$1.2M 0.03%
7,950
-1,186
-13% -$186K
TSN icon
387
Tyson Foods
TSN
$20.2B
$1.2M 0.03%
17,945
+3,066
+21% +$199K
AVDL
388
DELISTED
Avadel Pharmaceuticals
AVDL
$1.19M 0.03%
111,000
– –
BSX icon
389
Boston Scientific
BSX
$65.8B
$1.19M 0.03%
51,012
-205,076
-80% -$4.44M
GMED icon
390
Globus Medical
GMED
$10.4B
$1.19M 0.03%
50,000
-14,000
-22% -$336K
AORT icon
391
Artivion
AORT
$1.23B
$1.18M 0.03%
100,000
+14,000
+16% +$165K
CME icon
392
CME Group
CME
$92.2B
$1.17M 0.03%
12,050
+2,598
+27% +$246K
MACK
393
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.17M 0.03%
27,581
– –
EEM icon
394
iShares MSCI Emerging Markets ETF
EEM
$28B
$1.17M 0.03%
33,922
-7,579
-18% -$254K
NSC icon
395
Norfolk Southern
NSC
$78.8B
$1.17M 0.03%
13,696
+1,601
+13% +$136K
CBIO
396
Crescent Biopharma
CBIO
$602M
$1.16M 0.03%
1,600
-499
-24% -$344K
ROK icon
397
Rockwell Automation
ROK
$51.4B
$1.16M 0.03%
10,111
-10
-0.1% -$1.15K
SGMO
398
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.16M 0.03%
200,000
– –
ACHN
399
DELISTED
Achillion Pharmaceuticals
ACHN
$1.15M 0.03%
148,000
-137,000
-48% -$1.18M
APD icon
400
Air Products & Chemicals
APD
$66.3B
$1.15M 0.03%
8,757
+1,692
+24% +$225K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.